← All stories
Markets
Definium Therapeutics Announces New Employee Inducement Grants
NEW YORK — Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric and neurological disorder…
Covered by 1 outlet
All coverage · 1 article